Modernizing Opioid Treatment Access Act 2.0 of 2026 expands access to methadone for opioid use disorder through pharmacies.
Modernizing Opioid Treatment Access Act 2.0 of 2026 amends the Controlled Substances Act to expand access to methadone for opioid use disorder. It waives certain requirements and allows the Attorney General to register practitioners to prescribe methadone for dispensing through pharmacies. These practitioners must ensure informed consent and document specific consent regarding confidentiality protections. The bill also allows maintenance or detoxification treatment through telemedicine and requires annual reporting by the Drug Enforcement Administration.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.